OGN - Healthcare gainers for the week led by CLOV's meme-stock fever CureVac falls on delay in regulatory approval for COVID vaccine

Healthcare sector and Real Estate Select Sector SPDR ETF (XLRE) gain of 1.92% and 1.88% respectively during the week outpaced S&P 500 gain of +0.40%.Looking at larger stocks (over $2B market capitalization), far and away the sector's top gainer was "meme stock" favorite Clover Health (NYSE:CLOV), ended the week 67% higher, bringing it around a $5.85B market cap.Clover Health Investments +67%. BofA downgraded the stock on valuation after the stock gained 145% in the first two trading days of the week.Biogen (BIIB) +38.6%. Stock rallied 38% on Monday following the news of FDA approval for its Alzheimer's disease treatment Aduhelm (aducanumab). The analyst has offered contrasting views on the commercial success of the therapy.SA contributor Lane Simonian remarks on how the FDA Got It Wrong In Approving Biogen's Aducanumab For Alzheimer's Disease.Apollo Medical Holdings (AMEH) +30.9%. Shares gained on inclusion into the S&P SmallCap 600 index.IOVA +30.9%. The company announced 33-month follow up data for lifileucel in advanced melanoma at ASCO21. JMP raises Iovance to

For further details see:

Healthcare gainers for the week led by CLOV's meme-stock fever, CureVac falls on delay in regulatory approval for COVID vaccine